Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
KYTX
Kyverna Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2024
Get push alerts for KYTX
Full KYTX profile on Quantisnow Follow KYTX and get a push notification the moment its next story breaks.